摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(5E,7E,1S,3R,10R)-3-acetoxy-9,10-seco-5,7-cholestadiene-1,25-diol | 157637-98-4

中文名称
——
中文别名
——
英文名称
(5E,7E,1S,3R,10R)-3-acetoxy-9,10-seco-5,7-cholestadiene-1,25-diol
英文别名
——
(5E,7E,1S,3R,10R)-3-acetoxy-9,10-seco-5,7-cholestadiene-1,25-diol化学式
CAS
157637-98-4
化学式
C29H48O4
mdl
——
分子量
460.698
InChiKey
WCODSZIYCZHZMX-ZFWFONRBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.36
  • 重原子数:
    33.0
  • 可旋转键数:
    7.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.83
  • 拓扑面积:
    66.76
  • 氢给体数:
    2.0
  • 氢受体数:
    4.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (5E,7E,1S,3R,10R)-3-acetoxy-9,10-seco-5,7-cholestadiene-1,25-diol氢氧化钾 作用下, 以 乙醇 为溶剂, 反应 1.0h, 以68%的产率得到1,25-二羟基二氢速甾醇 (3)
    参考文献:
    名称:
    Synthesis, Conformational Analysis, and Biological-Activity of the 1-α,25-Dihydroxy-10,19-Dihydrovitamin D3 Isomers
    摘要:
    The synthesis of the four 1 alpha,25-dihydroxy-10,19-dihydrovitamin D-3 stereoisomers (8-11) is described starting from 25-hydroxyvitamin D-3 (1c). Acetic acid-catalyzed cycloreversion of 1 alpha-hydroxylated 3,5-cyclovitamin D compound 14, produced by allylic oxidation of the intermediate cyclovitamin 13, afforded 1 alpha,25-dihydroxyvitamin D-3 3-acetate (16) and its 5E-isomer 17. Catalytic hydrogenation of 16 produced 10,18-dihydrovitamin acetates 20 and 21, whereas the same reaction of 17 resulted in the formation of SE-isomers 22 and 23. The analogous saturation of the 10,19-double bond in 14 gave 10(S), 19- and 10(R), 19-dihydrocyclovitamins 18 and 19 which after cycloreversion with acetic acid yielded different stereoisomeric pairs of 10,19-dihydrovitamin acetates 21, 23, 20, and 22, respectively. The stereochemistry and solution conformations of the A-ring of the 3-acetates 20-23 and their parent alcohols 8-11 were studied using H-1 NMR data. The A-ring chair population ratios of these stereoisomers were determined by the method of correlation of the observed coupling constants with the limiting values derived from cyclohexanol. The obtained results were confirmed by evaluation of interaction energies introduced by A-ring substituents and calculation of the free energy differences between the respective dihydrovitamin conformers. Conformational analyses of 10,19-dihydrovitamins were also carried out on model compounds 24-27 by using force-field calculations. Biological activity in vivo revealed that the 1 alpha,25-dihydroxy-10(S), 19-dihydrovitamin D-3 (9) followed by the 1 alpha,25-dihydroxy-10(S), 19-dihydro-(5E)-vitamin D-3 (11) to be the most active, while the 10(R)-isomers 8 and 10 possessed little or no activity. In vitro, the compounds possessing the most equatorial 1-hydroxyl, i.e., the 10(R)-isomers, were found most active, and the least equatorial were the least active. (C) 1994 Academic Press, Inc.
    DOI:
    10.1006/bioo.1994.1013
  • 作为产物:
    参考文献:
    名称:
    Synthesis, Conformational Analysis, and Biological-Activity of the 1-α,25-Dihydroxy-10,19-Dihydrovitamin D3 Isomers
    摘要:
    The synthesis of the four 1 alpha,25-dihydroxy-10,19-dihydrovitamin D-3 stereoisomers (8-11) is described starting from 25-hydroxyvitamin D-3 (1c). Acetic acid-catalyzed cycloreversion of 1 alpha-hydroxylated 3,5-cyclovitamin D compound 14, produced by allylic oxidation of the intermediate cyclovitamin 13, afforded 1 alpha,25-dihydroxyvitamin D-3 3-acetate (16) and its 5E-isomer 17. Catalytic hydrogenation of 16 produced 10,18-dihydrovitamin acetates 20 and 21, whereas the same reaction of 17 resulted in the formation of SE-isomers 22 and 23. The analogous saturation of the 10,19-double bond in 14 gave 10(S), 19- and 10(R), 19-dihydrocyclovitamins 18 and 19 which after cycloreversion with acetic acid yielded different stereoisomeric pairs of 10,19-dihydrovitamin acetates 21, 23, 20, and 22, respectively. The stereochemistry and solution conformations of the A-ring of the 3-acetates 20-23 and their parent alcohols 8-11 were studied using H-1 NMR data. The A-ring chair population ratios of these stereoisomers were determined by the method of correlation of the observed coupling constants with the limiting values derived from cyclohexanol. The obtained results were confirmed by evaluation of interaction energies introduced by A-ring substituents and calculation of the free energy differences between the respective dihydrovitamin conformers. Conformational analyses of 10,19-dihydrovitamins were also carried out on model compounds 24-27 by using force-field calculations. Biological activity in vivo revealed that the 1 alpha,25-dihydroxy-10(S), 19-dihydrovitamin D-3 (9) followed by the 1 alpha,25-dihydroxy-10(S), 19-dihydro-(5E)-vitamin D-3 (11) to be the most active, while the 10(R)-isomers 8 and 10 possessed little or no activity. In vitro, the compounds possessing the most equatorial 1-hydroxyl, i.e., the 10(R)-isomers, were found most active, and the least equatorial were the least active. (C) 1994 Academic Press, Inc.
    DOI:
    10.1006/bioo.1994.1013
点击查看最新优质反应信息

同类化合物

(5β)-17,20:20,21-双[亚甲基双(氧基)]孕烷-3-酮 (5α)-2′H-雄甾-2-烯并[3,2-c]吡唑-17-酮 (3β,20S)-4,4,20-三甲基-21-[[[三(异丙基)甲硅烷基]氧基]-孕烷-5-烯-3-醇-d6 (25S)-δ7-大发酸 (20R)-孕烯-4-烯-3,17,20-三醇 (11β,17β)-11-[4-({5-[(4,4,5,5,5-五氟戊基)磺酰基]戊基}氧基)苯基]雌二醇-1,3,5(10)-三烯-3,17-二醇 齐墩果酸衍生物1 黄麻属甙 黄芪皂苷III 黄芪皂苷 II 黄芪甲苷 IV 黄芪甲苷 黄肉楠碱 黄果茄甾醇 黄杨醇碱E 黄姜A 黄夹苷B 黄夹苷 黄夹次甙乙 黄夹次甙乙 黄夹次甙丙 黄体酮环20-(乙烯缩醛) 黄体酮杂质EPL 黄体酮杂质1 黄体酮杂质 黄体酮杂质 黄体酮EP杂质M 黄体酮EP杂质G(RRT≈2.53) 黄体酮EP杂质F 黄体酮6-半琥珀酸酯 黄体酮 17alpha-氢过氧化物 黄体酮 11-半琥珀酸酯 黄体酮 麦角甾醇葡萄糖苷 麦角甾醇氢琥珀酸盐 麦角甾烷-6-酮,2,3-环氧-22,23-二羟基-,(2b,3b,5a,22R,23R,24S)-(9CI) 麦角甾烷-3,6,8,15,16-五唑,28-[[2-O-(2,4-二-O-甲基-b-D-吡喃木糖基)-a-L-呋喃阿拉伯糖基]氧代]-,(3b,5a,6a,15b,16b,24x)-(9CI) 麦角甾烷-26-酸,5,6:24,25-二环氧-14,17,22-三羟基-1-羰基-,d-内酯,(5b,6b,14b,17a,22R,24S,25S)-(9CI) 麦角甾-8-烯-3-醇 麦角甾-8,24(28)-二烯-26-酸,7-羟基-4-甲基-3,11-二羰基-,(4a,5a,7b,25S)- 麦角甾-7,22-二烯-3-酮 麦角甾-7,22-二烯-17-醇-3-酮 麦角甾-5,24-二烯-26-酸,3-(b-D-吡喃葡萄糖氧基)-1,22,27-三羟基-,d-内酯,(1a,3b,22R)- 麦角甾-5,22,25-三烯-3-醇 麦角甾-4,6,8(14),22-四烯-3-酮 麦角甾-1,4-二烯-3-酮,7,24-二(乙酰氧基)-17,22-环氧-16,25-二羟基-,(7a,16b,22R)-(9CI) 麦角固醇 麦冬皂苷D 麦冬皂苷D 麦冬皂苷 B